Side-by-side comparison of AI visibility scores, market position, and capabilities
Vancouver BC premium athletic apparel (NASDAQ: LULU) ~$10.6B FY2024 revenue (+11%); women's yoga apparel leader, China +41%, US slowdown, men's 22%+ of revenue, competing with Nike and Alo Yoga.
lululemon athletica inc. is a Vancouver, British Columbia-based premium athletic apparel company — publicly traded on the NASDAQ (NASDAQ: LULU) as an S&P 500 Consumer Discretionary component — designing, making, and distributing technical athletic apparel (yoga, run, train, swim, golf) and lifestyle products for women (primary market), men (growing), and youth through 700+ company-owned retail stores and e-commerce at lululemon.com through approximately 36,000 employees. In fiscal year 2024 (ending February 2025), lululemon reported revenues of approximately $10.6 billion (+11% year-over-year), continuing its decade-long consistent double-digit revenue growth as the brand expanded internationally (China mainland growing 41% in FY2024, Rest of World growing 28%) while US growth slowed to low single digits as the premium yoga-adjacent apparel market reached maturation levels in core US metro markets. CEO Calvin McDonald's strategy has focused on building the international business (China, Europe, rest of world) to replicate the North American penetration that drove lululemon's exceptional 2014-2023 growth, while managing the Mirror connected fitness acquisition write-off ($500 million full goodwill impairment of the Mirror home fitness acquisition completed in June 2020 for $500 million — mirror business essentially wound down by 2023) and navigating US market saturation challenges that required product innovation investment to sustain domestic revenue growth. lululemon's core women's leggings business (Align, Wunder Under, Fast and Free pants — $100-148 price point, premium Luon and Everlux fabric technology) anchors the brand's category authority in performance athletic bottoms.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.